Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease

NCT00770575 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Diseases

Interventions

DRUG: Pioglitazone and atorvastatin
DRUG: Atorvastatin

Sponsor

Takeda